Botanical species · safety record

Cirsium japonicum

The EFSA Compendium of Botanicals holds 6 constituent measurements for Cirsium japonicum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cirsium japonicum (Thunb.) Fisch. ex DC.

6Constituent measurements

0Safety records

5Cited sources

16Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 16 licensed products naming Cirsium japonicum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Herb top flowering
Whole plant

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Coumarin	Leaves	Solvent extraction	135.6 Milligram/kilogram	HPLC-UV	Resolve DOI
Polyacetylene derivatives	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Polyacetylene derivatives	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Eleutheroside b	Roots and other underground parts	—	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Lignans	Live plants	Solvent extraction	—	Unspecified	No resolvable identifier
P-coumaric acid	Roots and other underground parts	—	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Chon, SU., Kim, YM., Lee, JC. Herbicidal potential and quantification of causative allelochemicals from several Compositae weeds . Weed research, 2003, vol. 43, no. 6, p. 444-450. DOI
Zhi Fei., Kong Ling-yi., Peng Si-xun. Studies on the chemical constituents of Cirsium japonicum DC.. Yaoxue xuebao, 2003, vol. 38, no. 6, p. 442-447.
Lu, Ying., Duan, Shutao., Pan, Jiahu., Yu, Peizhong. Phytochemical investigation of cirsium japonicum DC.. Tianran chanwu yanjiu yu kaifa, 2009, p. 563-565.
Kang, Tae Jin., Moon, Jung Sun., Lee, Sookyeon., Yirn, Dongsool. Polyacetylene Compound from Cirsium japonicum var. ussuriense Inhibits the LPS-Induced Inflammatory Reaction via Suppression of NF-kappa B Activity in RAW 264.7 Cells. BIOMOLECULES & THERAPEUTICS, 2011, vol. 19, no. 1, p. 97-101. DOI
Lai, Wan-Chun., Wu, Yang-Chang., Danko, Balazs., Cheng, Yuan-Bin., Hsieh, Tusty-Jiuan., Hsieh, Chi-Ting., Tsai, Yu-Chi., El-Shazly, Mohamed., Martins, Ana., Hohmann, Judit., Hunyadi, Attila., Chang, Fang-Rong. Bioactive Constituents of Cirsium japonicum var. australe. JOURNAL OF NATURAL PRODUCTS, 2014, vol. 77, no. 7, p. 1624-1631. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature